The Role of EIF-3 Complex in Translation Initiation (P17844)
The Role of EIF-3 Complex in Translation Initiation
Eukaryotic translation initiation factor 3 (eIF-3) complex is a protein that plays a crucial role in the process of translation of RNA into protein in eukaryotic cells. It is a complex that consists of several subunits, including eIF-2, eIF-3, eIF-4, and eIF-5. The eIF-3 complex is involved in the formation of the eIF-3 complex, which is the first step in the process of translation initiation.
The eIF-3 complex is a protein that is expressed in most eukaryotic cells and is involved in the process of translation initiation. It is a complex that consists of several subunits, including eIF-2, eIF-3, eIF-4, and eIF-5. The eIF-3 complex is involved in the formation of the eIF-3 complex, which is the first step in the process of translation initiation.
One of the subunits of the eIF-3 complex is eIF-3 itself. EIF-3 is a protein that is composed of several domains, including a nucleotide-binding domain, a transmembrane domain, and a cytoplasmic domain. The nucleotide-binding domain is the region of the protein that binds to specific nucleotides, while the transmembrane domain is the region of the protein that is involved in the formation of the eIF-3 complex. The cytoplasmic domain is the region of the protein that is involved in its localization and stability.
The eIF-3 complex is involved in the process of translation initiation by helping to establish a favorable environment for the initiation of the process. The eIF-3 complex forms a protein-protein interaction network that is involved in the regulation of translation initiation. It does this by interacting with several other proteins, including the factors that initiate the process of translation.
One of the functions of the eIF-3 complex is to regulate the translation of specific genes. This is done by binding to specific DNA sequences and preventing the translation of the RNA that is associated with those genes. This helps to ensure that the cell only expresses the proteins that are necessary for its survival and growth.
The eIF-3 complex is also involved in the regulation of protein stability. This is done by helping to ensure that the proteins that are synthesized by the cell are stable and can be translated into the desired form. This helps to prevent the degradation of the proteins that are synthesized and ensures that they can perform their intended functions.
The eIF-3 complex is also involved in the regulation of cell signaling pathways. This is done by interacting with the signaling proteins that are involved in the regulation of cellular processes. This helps to ensure that the signaling pathways are properly regulated and that the cell is able to respond to changes in its environment.
In conclusion, the eIF-3 complex is a protein that is involved in the process of translation initiation in eukaryotic cells. It is a complex that consists of several subunits, including eIF-2, eIF-3, eIF-4, and eIF-5. The eIF-3 complex is involved in the formation of the eIF-3 complex, which is the first step in the process of translation initiation. It is also involved in the regulation of translation initiation, protein stability, and cell signaling pathways. Therefore, the eIF-3 complex is a potential drug target and could be a biomarker for the treatment of various diseases.
Protein Name: Eukaryotic Translation Initiation Factor 3 (eIF-3) Complex
The "Eukaryotic translation initiation factor 3 (eIF-3) complex Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Eukaryotic translation initiation factor 3 (eIF-3) complex comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
Eukaryotic Translation Initiation Factor 4A (eIF-4A) | Eukaryotic Translation Initiation Factor 4E Binding Protein | EVA1A | EVA1A-AS | EVA1B | EVA1C | EVC | EVC2 | EVI2A | EVI2B | EVI5 | EVI5L | EVL | EVPL | EVPLL | EVX1 | EVX1-AS | EVX2 | EWSAT1 | EWSR1 | EXD1 | EXD2 | EXD3 | EXO1 | EXO5 | EXOC1 | EXOC1L | EXOC2 | EXOC3 | EXOC3-AS1 | EXOC3L1 | EXOC3L2 | EXOC3L4 | EXOC4 | EXOC5 | EXOC5P1 | EXOC6 | EXOC6B | EXOC7 | EXOC8 | Exocyst complex | EXOG | EXOGP1 | Exon junction complex | EXOSC1 | EXOSC10 | EXOSC10-AS1 | EXOSC2 | EXOSC3 | EXOSC4 | EXOSC5 | EXOSC6 | EXOSC7 | EXOSC8 | EXOSC9 | Exosome Complex | EXPH5 | EXT1 | EXT2 | EXTL1 | EXTL2 | EXTL2P1 | EXTL3 | EXTL3-AS1 | EYA1 | EYA2 | EYA3 | EYA4 | EYS | EZH1 | EZH2 | EZHIP | EZR | F10 | F11 | F11-AS1 | F11R | F12 | F13A1 | F13B | F2 | F2R | F2RL1 | F2RL2 | F2RL3 | F3 | F5 | F7 | F8 | F8A1 | F8A2 | F8A3 | F9 | FA2H | FAAH | FAAH2 | FAAHP1 | FAAP100 | FAAP20 | FAAP24
